Bringing together leading researchers in signal transduction from across Canada and abroad
Signalling in Normal and Cancer Cells Conference
The Marathon of Hope Cancer Centres Network and the Terry Fox Research Institute are happy to support the 12th Signalling in Normal and Cancer Cells Conference, which will be held in Banff, AB on April 23 - 27. The conference brings together leading researchers in signal transduction from across Canada and abroad, including a number of researchers supported by the Marathon of Hope Cancer Centres Network.
Learn more about the event and register, here.
Visit event Website
About the Event
In each edition, the Conference on Signalling in Normal and Cancer Cells brings together leading researchers in signal transduction from across Canada and the world. These researchers are involved in various aspects of cell signalling research, from the membrane to the nucleus and from basic research to translational research.
The conference in a nutshell
- Speakers and attendees from 20+ universities and research centres in Canada, the US, Europe, and other countries
- 100 to 150 participants per edition
- 60% Investigators, 40% trainees
- 4 days
- 7 sessions
- 6 nutri break/coffee breaks
- 32 speakers
- 10 short talks / 3 Marathon of Hope Cancer Centres Network - MOHCCN Sessions
- 4 poster sessions
With a history of almost 30 years in Canada, it is the premier venue for cell signalling researchers to connect and exchange ideas (and enjoy the sun and snow of the beautiful Rocky Mountains).
List of MOHCCN Speakers participating in the event
Enfu Hui | April 26: Immune regulation of cancer progression |
Ian Watson | April 26: Immune regulation of cancer progression |
Janessa Laskin | April 25: Improving outcomes of hard-to-treat cancer with precision oncology |
Dan Renouf | April 25: Improving outcomes of hard-to-treat cancer with precision oncology |
Brad Nelson | April 26: Immune regulation of cancer progression |
Marco Marra | April 26: Keynote |
Trevor Pugh | April 25: Improving outcomes of hard-to-treat cancer with precision oncology |
Nizar Bahlis | April 25: Improving outcomes of hard-to-treat cancer with precision oncology |
Daniela Quail | April 26: Immune regulation of cancer progression |
Morag Park | April 24: Signalling in the Tumor Microenvironment (Non-MOHCCN session) |
André Veillette | April 24: Signalling in the Tumor Microenvironment (Non-MOHCCN session) |
Jim Woodgett | April 26: Kinases and Ras proteins (Non-MOHCCN session) |